WEBULL
News
MLAB
90.40
-1.69%
-1.55
Weekly Report: what happened at MLAB last week (0202-0206)?
Weekly Report · 2d ago
Mesa Labs Is Maintained at Equal-Weight by Wells Fargo
Dow Jones · 02/04 15:04
Wells Fargo Maintains Equal-Weight on Mesa Laboratories, Raises Price Target to $94
Benzinga · 02/04 14:54
Mesa Labs price target raised to $94 from $83 at Wells Fargo
TipRanks · 02/04 11:36
MESA LABORATORIES, INC. <MLAB.O>: WELLS FARGO RAISES TARGET PRICE TO $94 FROM $83
Reuters · 02/04 11:21
U.S. RESEARCH ROUNDUP- Ametek, Coca-Cola, Pepsico
Reuters · 02/04 06:59
Mesa Laboratories (MLAB) Quarterly Profit Return Tests Longstanding Bearish Loss Narratives
Simply Wall St · 02/04 00:51
Mesa Laboratories' Shares Up on Swing to Profit, Stabilizing Demand
Dow Jones · 02/03 17:03
Mesa Laboratories Earnings Review: Q3 Summary
Benzinga · 02/03 13:58
Mesa Laboratories Q3 Earnings Report: What Investors Need to Know
Benzinga · 02/03 13:36
Mesa Laboratories Earnings Report: Q3 Overview
Benzinga · 02/03 13:30
Insights into Mesa Laboratories Q3 Earnings
Benzinga · 02/03 13:24
Earnings Breakdown: Mesa Laboratories Q3
Benzinga · 02/03 13:18
Mesa Laboratories Q3 Earnings Assessment
Benzinga · 02/03 13:12
Mesa Laboratories Inc. unveils investor presentation highlighting growth in life science quality control solutions
Reuters · 02/03 13:10
Mesa Laboratories veröffentlicht Präsentation zu Qualitätskontrolllösungen für die Life Sciences-Branche
Reuters · 02/03 13:10
Mesa Laboratories Q3 revenue rises 3.6%
Reuters · 02/03 13:07
Mesa Laboratories GAAP EPS of $0.65 beats by $0.37, revenue of $65.13M beats by $1.9M
Seeking Alpha · 02/03 13:06
Mesa Labs reports Q3 EPS 65c vs (31c) last year
TipRanks · 02/03 13:05
Mesa Laboratories Q3 Adj. EPS $3.07, Sales $65.126M Beat $63.359M Estimate
Benzinga · 02/03 13:05
More
Webull provides a variety of real-time MLAB stock news. You can receive the latest news about Mesa Laboratories through multiple platforms. This information may help you make smarter investment decisions.
About MLAB
Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. The Company's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.